References
- Floratos DL, Sedelaar JPM, Kortmann BBM, Aarnink RG, Wijkstra H, Debruyne FM, et al. Intra-prostatic vasculature studies: can they predict outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction?. Prostate 2001; 46: 200–6
- Bhowmick P, Coad JE, Bhowmick S, Pryor JL, Larson T, De la Rosette J, et al. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int J Hyperthermia 2004; 20: 421–39
- Devonec M, Tomera K, Perrin O. Transurethral thermotherapy. Monogr Urol 1992; 137: 77–9
- Huidobro C, Bolmsjö M, Larson T, de la Rosette J, Wagrell L, Schellin S, et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 2004; 171: 672–8
- Larson BT, Collins JM, Huidobro C, Corica A, Vallejo S, Bostwick DG. Gadolinium-enhanced MRI in the evaluation of minimally invasive treatments of the prostate: correlation with histopathologic findings. Urology 2003; 62: 900–4
- Osman Y, Wadie T, El-Diasty T, Larson T. High-energy transurethral microwave thermotherapy: symptomatic vs urodynamic success. BJU Int 2003; 91: 365–70
- Luypaert R, Boujraf S, Sourbron S, Osteaux M. Diffusion and perfusion MRI: basic physics. Eur J Radiol 2001; 38: 19–27
- Bolmsjö M, Schelin S, Wagrell L, Larson T, de la Rosette JJ, Mattiasson A. Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 2000; 14: 627–31
- Walmsley K, Kaplan SA. Transurethral microwave thermotherapy for benign prostate hyperplasia: separating the truth from marketing hype. J Urol 2004; 172: 1249–55
- Vesely S, Knutson T, Dicuio M, Damber JE, Dahlstrand C. Transurethral microwave thermotherapy: clinical results after 11 years of use. J Endourol 2005; 19: 730–3
- Nordenstam G, Aspelin P, Isberg B, Svensson L, Hallin A, Berlin T. Effect of transurethral microwave thermotherapy. An evaluation with MR imaging. Acta Radiol 1996; 37: 933–6
- De la Rosette JJ, Francisca EA, Kortman BB, Floratos DL, Debruyne FM, Kiemeney LA. Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: initial results. BJU Int 2000; 86: 47–51
- Hoffmann AL, Laguna MP, de la Rosette JJ, Wijkstra H. Quantification of prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur Urol 2003; 43: 181–7
- Wagrell L, Schelin S, Bolmsjo M, Brudin L. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998; 159: 1583–7
- De la Rosette JJ, Gravas S, Laguna P, Schelin S, Wagrell L, Larson T. Correlations between prostate volume reduction and clinical variables after microwave thermotherapy. J Urol 2003; (Suppl 169): 347 (Abstract DP32)
- Al-Rimawi M, Griffiths DJ, Boake RC, Mador DR, Johnson MA. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol 1994; 74: 596–600
- Hayami S, Ushiyama S, Kurita Y, Kageyama S, Suzuki K, Fujita K. The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia. Prostate 2002; 53: 168–72
- Ishida J, Sugimura K, Okizuka H, Kaji Y, Moriyama M, Nagaoka S, et al. Benign prostatic hyperplasia: value of MR imaging for determining histologic type. Radiology 1994; 190: 329–33
- D'Ancona FC, Albers YH, Kiemeney LA, Xue Y, Smedts F, van der Poel HG, et al. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate 1999; 40: 28–34
- Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001; 46: 1054–8